NCT05704036View on ClinicalTrials.gov

Estrogen Supplementation and Bone Health in Women With CF

PHASE4RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 2, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cystic FibrosisHypoestrogenism
Interventions
DRUG

Transdermal estrogen

Transdermal estradiol 0.1 mg/day, applied once weekly

DRUG

Progesterone

Progesterone 200 mg daily for 10 days/month, if participant is not on progesterone-containing contraceptive

Trial Locations (1)

21287

RECRUITING

Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

Johns Hopkins University

OTHER